Un problème de pratique quotidienne: l'allongement du temps de céphaline-activateur = A practical everyday problem: increased cephalin activator timeDROUET, L.STV. Sang thrombose vaisseaux. 1993, Vol 5, Num 9, pp 647-649, issn 0999-7385Article

Correlation of ACT as measured with three commercially available devices with circulating heparin level during cardiac surgeryNILES, S. D; SUTTON, R. G; PLOESSL, J et al.The Journal of extra-corporeal technology. 1995, Vol 27, Num 4, pp 197-200, issn 0022-1058Conference Paper

Validation of a new whole blood coagulation monitoring systemJARYNO, Stacy; BENNETT, Kim; LODER, Carol et al.The Journal of extra-corporeal technology. 2002, Vol 34, Num 4, pp 271-275, issn 0022-1058, 5 p.Conference Paper

Anticoagulant management in interventional cardiology : Monitoring heparin using act instrumentationOGILBY, J. D; CARVILLE, D. G. M.Cardiovascular reviews & reports. 1998, Vol 19, Num 11, pp 34-47, issn 0197-3118, 7 p.Article

Comparison of high-dose thrombin time with activated clotting time for monitoring of anticoagulant effects of heparin in cardiac surgical patientsJIAN-SHENG WANG; CHUNG-YUAN LIN; KARP, R. B et al.Anesthesia and analgesia. 1994, Vol 79, Num 1, pp 9-13, issn 0003-2999Article

In vitro effects of aprotinin on activated clotting time measured with different activatorsJIAN-SHENG WANG; CHUNG-YUAN LIN; WEI-TE HUNG et al.Journal of thoracic and cardiovascular surgery. 1992, Vol 104, Num 4, pp 1135-1140, issn 0022-5223Article

Variability of the activated coagulation timeGRAVLEE, G. P; CASE, L. D; ANGERT, K. C et al.Anesthesia and analgesia. 1988, Vol 67, Num 5, pp 469-472, issn 0003-2999Article

APPARATUS : Validation of a bedside activated clotting time test (Hemochron® Jr II Signature) with low dose heparin therapyRACIOPPI, L; QUINART, A; BIAIS, M et al.Anaesthesia. 2009, Vol 64, Num 4, pp 430-434, issn 0003-2409, 5 p.Article

New technology, old standards: Disparate activated clotting time measurements by the Hemochron Jr compared with the standard HemochronAYLSWORTH, Christopher L; STEFAN, Faith; WOITAS, Karl et al.The Annals of thoracic surgery. 2004, Vol 77, Num 3, pp 973-976, issn 0003-4975, 4 p.Article

Validation of the i-STAT handheld activated clotting time for use with BivalirudinSCHUSSLER, Jeffrey M; LANDER, Stuart R; WISSINGER, Laurie A et al.The American journal of cardiology. 2004, Vol 93, Num 10, pp 1318-1319, issn 0002-9149, 2 p.Article

In vivo demonstration of an antithrombin effect of AbciximabAMBROSE, J. A; HAWKEY, M; DOSS, R et al.The American journal of cardiology. 2000, Vol 86, Num 2, pp 150-152, issn 0002-9149Article

New insights into how blood clots : Implications for the use of APTT and PT as coagulation screening tests and in monitoring of anticoagulant therapyBAJAJ, S. P; JOIST, J. H.Seminars in thrombosis and hemostasis. 1999, Vol 25, Num 4, pp 407-418, issn 0094-6176Article

Les tests délocalisés auprès du malade pour adapter les traitements anticoagulants oraux = Delocalised patient testing for controling oral anticoagulant therapyTRIPODI, A; DROUET, L.STV. Sang thrombose vaisseaux. 1998, Vol 10, Num 7, pp 404-407, issn 0999-7385Article

Effect of hemodilution with dextran and albumin on activated clotting time (ACT)INOUE, M; HIROSE, Y; GAMOU, M et al.Masui. 1997, Vol 46, Num 6, pp 809-812, issn 0021-4892Article

The effect of lysed platelets on neutralization of heparin in vitro with protamine as measured by the activated coagulation time (ACT)BODE, A. P; CASTELLANI, W. J; HODGES, E. D et al.Thrombosis and haemostasis. 1991, Vol 66, Num 2, pp 213-217, issn 0340-6245Article

Activated clotting time (ACT): the reproducibility of three techniquesSILLICK, P. V; AMIOT, D. M; PANCNER, G et al.The Journal of extra-corporeal technology. 1987, Vol 19, Num 3, pp 265-267, issn 0022-1058Conference Paper

Correlations Between Activated Clotting Time Values and Heparin Concentration Measurements in Young Infants Undergoing Cardiopulmonary BypassGUZZETTA, Nina A; MONITZ, Heather G; FERNANDEZ, Janet D et al.Anesthesia and analgesia. 2010, Vol 111, Num 1, pp 173-179, issn 0003-2999, 7 p.Article

The effect of heparin-coated pulmonary artery catheters on activated coagulation time in cardiac surgical PatientsHAERING, J. M; MASLOW, A. D; PARKER, R. A et al.Journal of cardiothoracic and vascular anesthesia. 2000, Vol 14, Num 3, pp 260-263, issn 1053-0770Article

The prolonged activated clotting time (ACT) with aprotinin depends on the type of activator used for measurementWENDEL, H. P; HELLER, W; GALLIMORE, M. J et al.Blood coagulation & fibrinolysis. 1993, Vol 4, Num 1, pp 41-45, issn 0957-5235Article

An evaluation of two activated clotting time monitors during cardiac surgeryREICH, D. L; ZAHL, K; PERUCHO, M. H et al.Journal of clinical monitoring. 1992, Vol 8, Num 1, pp 33-36, issn 0748-1977Article

Change in Heparin Potency and Effects on the Activated Clotting Time in Children Undergoing Cardiopulmonary BypassGUZZETTA, Nina A; AMIN, Sapan J; TOSONE, Alexandra K et al.Anesthesia and analgesia. 2012, Vol 115, Num 4, pp 921-924, issn 0003-2999, 4 p.Article

Evaluating the optimal activated clotting time during carotid artery stentingSAW, Jacqueline; BAJZER, Christopher; CASSERLY, Ivan P et al.The American journal of cardiology. 2006, Vol 97, Num 11, pp 1657-1660, issn 0002-9149, 4 p.Article

Value of monitoring activated clotting time when bivalirudin is used as the sole anticoagulation agent for percutaneous coronary interventionCHENEAU, Edouard; CANOS, Daniel; KUCHULAKANTI, Pramod K et al.The American journal of cardiology. 2004, Vol 94, Num 6, pp 789-792, issn 0002-9149, 4 p.Article

The in vitro effects of antithrombin III on the activated coagulation time in patients on heparin therapyLEVY, J. H; MONTES, F; SZLAM, F et al.Anesthesia and analgesia. 2000, Vol 90, Num 5, pp 1076-1079, issn 0003-2999Article

Effect of heparin-bonded pulmonary artery catheters on the activated coagulation timeMCNULTY, S. E; MAGUIRE, D. P; THOMAS, R. E et al.Journal of cardiothoracic and vascular anesthesia. 1998, Vol 12, Num 5, pp 533-535, issn 1053-0770Article